CryoPort, Inc. Begins Frozen Shipments for ABC Laboratories, Inc.

Company Expands Footprint in the Growing Indian Market

LAKE FOREST, CA -- (MARKET WIRE) -- 11/13/08 -- CryoPort, Inc. (OTCBB: CYRX) today announced that it has begun shipments of frozen samples for Analytical Bio-Chemistry Laboratories, Inc. (ABC), to India. These CryoPort Express(TM) shipments will be the first in a series of shipments to an ABC affiliate in Bangalore.

The shipments will provide an opportunity to expand CryoPort's geographic footprint in India as ground-based capabilities are reinforced. These shipments will provide invaluable experience as CryoPort expands its business in India.

Peter Berry, CEO of CryoPort, commented, "The shipments for ABC, in addition to addressing a temperature control issue for shipments to India, has also provided diverse experience in terms of sample materials and configuration to ensure we are flexible in successfully adapting the CryoPort Express service to emerging opportunities in the developing world. India looks to be a proving ground for the CryoPort Express Shipper."

To be added to the CryoPort Investor email list, please email with CYRX in the subject line.

About CryoPort, Inc.

CryoPort ( develops leading edge, proprietary, technology-driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed by CryoPort are essential components of the infrastructure required for the testing, research and end user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment.


This press release contains forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Stuart Fine
Carpe DM, Inc.